24 Nov

Application for quotation of securities - MXC

Application for quotation of +securities Application for quotation of +securities 1 / 8 Announcement Summary Entity name MGC PHARMACEUTICALS LTD Announcement Type New announcement Date of this announcement Wednesday November 24, 2021 The +securities to be quoted are: Total number of +securities to be quoted ASX +security code Security description Number of +securities to be quoted Issue date MXC ORDINARY FULLY PAID 800,000 24/11/2021 Refer to next page for full details of the announcement +Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted Application for quotation of +securities Application for quotation of +securities 2 / 8 Part 1 - Entity and announcement details 1.1 Name of entity MGC PHARMACEUTICALS LTD We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules. 1.2 Registered number type ABN Registration number 30116800269 1.3 ASX issuer code MXC 1.4 The announcement is 1.5 Date of this announcement 24/11/2021 New announcement Application for quotation of +securities Application for quotation of +securities 3 / 8 Part 2 - Type of Issue 2.1 The +securities to be quoted are: 2.2 The +securities to be quoted are: Additional +securities in a class that is already quoted on ASX ("existing class") +Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted Application for quotation of +securities Application for quotation of +securities 4 / 8 Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B Existing +securities converting into additional +securities in an existing class FROM (Existing Class) ASX +security code and description MXCAAD : CLASS C PERFORMANCE RIGHTS TO (Existing Class) ASX +security code and description MXC : ORDINARY FULLY PAID Please state the number of options that were exercised or other +convertible securities that were converted 600,000 The first date the options were exercised or other +convertible securities were converted 23/11/2021 The last date the options were exercised or other +convertible securities were converted 23/11/2021 Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)? The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by: The underlying securities being received by the holder are: Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? Provide details of the KMP or +associates who are exercising options or converting convertible securities Name of KMP Name of registered holder Number of options being exercised or other +convertible securities being converted Ross Grant Thomas Walker Ross G T Walker Pty LTd 600,000 Yes Yes Intended to be, but are not yet, quoted by ASX An issue of new +securities No Application for quotation of +securities Application for quotation of +securities 5 / 8 Issue date 24/11/2021 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Issue details Number of +securities to be quoted 600,000 Are the +securities being issued for a cash consideration? Please describe the consideration being provided for the +securities The Performance Rights being exercised were granted under the Company's Employee Securities Incentive Plan and forms part of the Director's remuneration. Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.046000 Any other information the entity wishes to provide about the +securities to be quoted Existing +securities converting into additional +securities in an existing class FROM (Existing Class) ASX +security code and description MXCAG : PERFORMANCE RIGHTS TO (Existing Class) ASX +security code and description MXC : ORDINARY FULLY PAID Please state the number of options that were exercised or other +convertible securities that were converted 200,000 The first date the options were exercised or other +convertible securities were converted 26/10/2021 The last date the options were exercised or other +convertible securities were converted 26/10/2021 Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)? No Yes Application for quotation of +securities Application for quotation of +securities 6 / 8 exercised or have all of those convertible securities now been converted)? The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by: The underlying securities being received by the holder are: Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? Issue date 24/11/2021 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes No Yes Intended to be, but are not yet, quoted by ASX An issue of new +securities No Application for quotation of +securities Application for quotation of +securities 7 / 8 Issue details Number of +securities to be quoted 200,000 Are the +securities being issued for a cash consideration? Please describe the consideration being provided for the +securities The Performance Rights being exercised were granted under the Company's Employee Securities Incentive Plan and forms part of the Employee's remuneration. Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.046000 Any other information the entity wishes to provide about the +securities to be quoted No No Application for quotation of +securities Application for quotation of +securities 8 / 8 Part 4 - Issued capital following quotation Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise: (A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.) 4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application) ASX +security code and description Total number of +securities on issue MXC : ORDINARY FULLY PAID 2,404,895,855 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue MXCAF : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 51,300,000 MXCAG : PERFORMANCE RIGHTS 33,100,000 MXCAAA : CONVERTIBLE NOTES 2,100,000 MXCAAB : CLASS A PERFORMANCE RIGHTS 17,100,000 MXCAAC : CLASS B PERFORMANCE RIGHTS 39,900,000 MXCAAD : CLASS C PERFORMANCE RIGHTS 6,000,000 MXCAH : OPTION EXPIRING 31-MAR-2023 EX $0.026 7,692,308 MXCAI : OPTION EXPIRING 31-MAR-2023 EX GBP0.01475 26,440,678 MXCAAE : CLASS D PERFORMANCE RIGHTS 250,000 MXCAAF : CLASS E PERFORMANCE RIGHTS 250,000
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from MGC Pharmaceuticals Ltd (ASX:MXC) when you join Listcorp.